Despina Siolas, Assistant Professor at Weill Cornell Medicine, shared a post on LinkedIn:
“A standout talk yesterday at GI26 by William Adrian Hall on the application of artificial intelligence in oncology—thought-provoking, and a clear signal of where the field is heading.
He highlighted how computational histology and AI-powered biomarkers may inform treatment selection in pancreatic cancer, with real implications for precision care referencing work from Pancreatic Cancer Action Network (PanCAN) and Valar Labs. I look forward to seeing the results of their poster today which is recently accepted for publication. Exciting momentum for AI-driven precision oncology at GIASCO.”
More posts about Precision Oncology.